{
    "2019-10-15": [
        [
            {
                "time": "",
                "original_text": "康龙化成(300759.SZ)：第三季度净利预增42%-62%",
                "features": {
                    "keywords": [
                        "康龙化成",
                        "第三季度",
                        "净利预增",
                        "42%-62%"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "部分CRO&CDMO三季度业绩预告出炉，业绩分化明显 盈利能力下降",
                "features": {
                    "keywords": [
                        "CRO",
                        "CDMO",
                        "三季度",
                        "业绩分化",
                        "盈利能力下降"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "【康龙化成】19Q3预告点评：业绩显著超预期，协同效应效果显著",
                "features": {
                    "keywords": [
                        "康龙化成",
                        "19Q3",
                        "业绩显著超预期",
                        "协同效应",
                        "效果显著"
                    ],
                    "sentiment_score": 0.95,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}